510(k) K102964
K102964 is an FDA 510(k) premarket notification submitted by Grifols USA, Inc. for the device "EU-TTG IGA AND EU-TTG IGG". The FDA issued a decision of Substantially Equivalent on March 7, 2011. The device falls under product code MVM (Autoantibodies, Endomysial(Tissue Transglutaminase)), a Class II device regulated under 21 CFR 866.5660. Grifols USA, Inc. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 7, 2011
- Date Received
- October 5, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Autoantibodies, Endomysial(Tissue Transglutaminase)
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type